Protagonist Therapeutics, Inc — Director's Dealing 2016

Aug 11, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2016-08-10

Reporting Person: Liu David Y (Chief Scientific Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$0.87	2023-09-26	Common Stock (23767)		Direct
Employee Stock Option (right to buy)	$1.89	2024-10-22	Common Stock (20225)		Direct
Employee Stock Option (right to buy)	$1.89	2025-03-26	Common Stock (5998)		Direct
Employee Stock Option (right to buy)	$1.16	2025-10-28	Common Stock (35656)		Direct
Employee Stock Option (right to buy)	$4.21	2026-04-29	Common Stock (45831)		Direct

Footnotes

F1: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.

F2: The option vests over a four-year period, with 1/48th of the shares subject to the option vesting on the last day of each month following the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date.